Exosomal transfer of long non-coding RNA SBF2-AS1 enhances chemoresistance to temozolomide in glioblastoma

BACKGROUND: Acquired drug resistance is a constraining factor in clinical treatment of glioblastoma (GBM). However, the mechanisms of chemoresponsive tumors acquire therapeutic resistance remain poorly understood. Here, we aim to investigate whether temozolomide (TMZ) resistance of chemoresponsive G...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Zhuoran, Yin, Jianxing, Lu, Chenfei, Wei, Yutian, Zeng, Ailiang, You, Yongping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6469146/
https://www.ncbi.nlm.nih.gov/pubmed/30992025
http://dx.doi.org/10.1186/s13046-019-1139-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6469146/
https://www.ncbi.nlm.nih.gov/pubmed/30992025
http://dx.doi.org/10.1186/s13046-019-1139-6

Ejemplares similares